Cart
sales@molnova.com
S6K1-IN-DG2
CAS No. 871340-88-4
S6K1-IN-DG2( —— )
Catalog No. M34405 CAS No. 871340-88-4
S6K1-IN-DG2(S6K1InhibitorDG2) is a potent p70S6K inhibitor with an IC50 value of less than 100 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 85 | In Stock |
|
| 10MG | 132 | In Stock |
|
| 25MG | 256 | In Stock |
|
| 50MG | 385 | In Stock |
|
| 100MG | 536 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameS6K1-IN-DG2
-
NoteResearch use only, not for human use.
-
Brief DescriptionS6K1-IN-DG2(S6K1InhibitorDG2) is a potent p70S6K inhibitor with an IC50 value of less than 100 nM.
-
DescriptionS6K1-IN-DG2 (Compound 66) is a p70S6K inhibitor (IC50: < 100 nM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetmTOR
-
RecptormTOR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number871340-88-4
-
Formula Weight389.25
-
Molecular FormulaC16H17BrN6O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (128.45 mM; Ultrasonic )
-
SMILESBrC=1C2=C(N=CN=C2NN1)N3CCN(CC3)C4=C(OC)C=CC=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Neel K. Anand, et al. Kinase modulators and methods of use. Patent. WO2005117909.
molnova catalog
related products
-
Seco Rapamycin sodiu...
Seco-rapamycin is the first in vivo open-ring metabolite of rapamycin that does not affect mTOR.
-
mTOR inhibitor 10
A novel potent, selective mTOR inhibitor with biochemical IC50 of 21.7 nM for mTORC1.
-
PRT-060318
PRT-060318 (PRT318) is a novel selective inhibitor of the Syk tyrosine kinase, as an approach to HIT treatment.
